Electromed, Inc. carries a market capitalization of 295.18M, placing it among publicly traded companies globally. Its enterprise value stands at 176.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 295.18M |
| Enterprise Value | 176.96M |
Electromed, Inc. currently has 8.28M shares outstanding.
| Shares Outstanding | 8.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Electromed, Inc. trades at a trailing price-to-earnings ratio of 19.20. The price-to-sales ratio is 2.70, and the price-to-book ratio stands at 7.69.
| PE Ratio | 19.20 |
| PS Ratio | 2.70 |
| PB Ratio | 7.69 |
| P/TBV Ratio | 4.06 |
| P/FCF Ratio | 19.31 |
| P/OCF Ratio | 18.42 |
On an enterprise value basis, Electromed, Inc. trades at an EV/EBITDA multiple of 12.38 and an EV/FCF ratio of 16.81. The EV/Sales ratio of 2.47 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.51 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.47 |
| EV / EBITDA | 12.38 |
| EV / EBIT | 13.51 |
| EV / FCF | 16.81 |
Electromed, Inc. maintains a current ratio of 4.91, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.91 |
| Quick Ratio | 4.53 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Electromed, Inc. posts a return on equity of 42.22 and a return on invested capital of 20.96.
| Return on Equity (ROE) | 42.22 |
| Return on Assets (ROA) | 18.05 |
| Return on Invested Capital (ROIC) | 20.96 |
| Return on Capital Employed (ROCE) | 42.22 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.94 |
Over the trailing twelve months, Electromed, Inc. has paid 3.47M in income taxes, reflecting an effective tax rate of 25.56.
| Income Tax | 3.47M |
| Effective Tax Rate | 25.56 |
Electromed, Inc.'s stock has gained approximately 76.92308% over the past 52 weeks. The 50-day moving average sits at 28.60, while the 200-day moving average is 26.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | 76.92308% |
| 50-Day Moving Average | 28.60 |
| 200-Day Moving Average | 26.36 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Electromed, Inc. generated 71.75M in revenue and converted that into 10.10M in net income, yielding earnings per share of 1.16. EBITDA reached 14.30M, while operating income came in at 13.10M.
| Revenue | 71.75M |
| Gross Profit | 56.28M |
| Operating Income | 13.10M |
| Pretax Income | 13.57M |
| Net Income | 10.10M |
| EBITDA | 14.30M |
| EBIT | 13.10M |
| Earnings Per Share (EPS) | 1.16 |
Total book value stands at 25.22M, with working capital of 40.00M providing operational flexibility.
| Cash & Cash Equivalents | 16.99M |
| Total Debt | N/A |
| Net Debt | -16.98M |
| Equity (Book Value) | 25.22M |
| Book Value Per Share | 3.04 |
| Working Capital | 40.00M |
Electromed, Inc. produced 10.53M in operating cash flow over the past twelve months.
| Operating Cash Flow | 10.53M |
| Capital Expenditures | N/A |
| Free Cash Flow | 10.53M |
| FCF Per Share | 1.27 |
Electromed, Inc. operates with a gross margin of 78.44, reflecting its pricing power and cost economics. The operating margin of 18.25 and net profit margin of 14.08 provide insight into operational efficiency.
| Gross Margin | 78.44 |
| Operating Margin | 18.25 |
| Pretax Margin | 18.92 |
| Profit Margin | 14.08 |
| EBITDA Margin | 19.93 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 3.89 |
| FCF Yield | 5.18 |
Electromed, Inc. posts an Altman Z-Score of 14.70, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 14.70 |